Pharmafile Logo
Pharmafocus logo
Advanced Search

lilly

Showing 15 posts of 211 posts found.

alzheimers_brain

Lilly, Biogen and Roche debut Alzheimer’s disease drug results

July 22, 2015
Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …

News
Lilly image

Lilly and Immunocore collaborate on melanoma

June 29, 2015
Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly

Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …

News
Lilly image

UK Court weighs in on Lilly-Actavis Alimta case

June 26, 2015
Medical Communications, Sales and Marketing Actavis, Alimta, UK, lilly

Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …

News
Lilly image

Lilly and Novartis face legal challenges

June 25, 2015
Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

News
jeffrey_kasher

DrugDev looks to Lilly for chairman role

June 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drugdev, jeffrey kasher, lilly

Dr Jeffrey Kasher has joined US healthcare tech firm DrugDev as the chairman of its advisory board. Kasher takes 28 …

Appointment
lilly_logo_building

Lilly and AstraZeneca collaborate on cancer trials

May 29, 2015
Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I

AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …

News
lilly

Two new diabetes drugs approved

May 28, 2015
Sales and Marketing Japan, Takeda, diabetes in China, lilly

Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …

News
Bayer image

Bayer wins Cancer Drugs Fund appeal

May 22, 2015
Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly

Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …

News
FDA image

FDA issues more diabetes drug warnings

May 18, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Boehringer, J&J, JJ, lilly

The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …

News
Actos image

Takeda pays $2.7 billion to settle Actos lawsuits

May 1, 2015
Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2

Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …

News
Sanofi image

Sanofi rules out Toujeo discount in diabetes

April 14, 2015
Sales and Marketing 100 U/mL, Boehringer, Lantus, insulin glargine [rDNA origin] injection, lilly, toujeo

Sanofi has revealed that it will not discount its new insulin Toujeo more than its current blockbuster Lantus, despite lacking …

News
Pfizer image

Pfizer is pharma’s biggest advertiser

March 31, 2015
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, advertising, adverts, dtc, lilly

US giant Pfizer spends far more on direct-to-consumer advertising than any other pharma firm according to new data from Kantar …

News
EMA image

EMA committee recommends five drugs for approval

March 30, 2015
Sales and Marketing Boehringer, CHMP, EMA, Eisai, Europe, Gardasil, Lenvima, Merck, akynzio, jardiance, lilly

Cancer and diabetes treatments are among those given the go ahead in the latest round of approvals by the EMA. …

News

Lilly and Boehringer diabetes drug sees US launch

March 24, 2015
Sales and Marketing Boehringer, Glyxambi, Tradjenta, diabetes, empagliflozin/linagliptin, lilly, linagliptin

Lilly and Boehringer Ingelheim’s combo diabetes drug Glyxambi is now available to treat adult patients in the US. Glyxambi (empagliflozin/linagliptin) …

News
FDA image

FDA lifts ban on Pfizer Lilly pain study

March 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab

Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026